TL;DR
Compound tirzepatide is not a generic form of Zepbound or Mounjaro. A compounding pharmacy or outsourcing facility prepares each product, and the finished drug is not FDA approved. Access depends on the prescription, clinical need, pharmacy type, current federal policy, state law, and the patient’s location.
Compound Tirzepatide: What It Is and What Changed
A licensed compounding pharmacy or outsourcing facility prepares compounded tirzepatide for a permitted need. The finished product is not FDA approved and should not be described as a cheaper generic.
The FDA’s decision that the tirzepatide injection shortage was resolved narrowed the circumstances in which compounders could routinely make copies of approved tirzepatide drugs. It did not necessarily prohibit every patient-specific compounded prescription.
Availability may depend on:
- The prescription and documented clinical need
- Whether the pharmacy operates under section 503A or 503B
- Current FDA policy and enforcement
- State pharmacy and prescribing laws
- Where the patient, prescriber, and pharmacy are located
Whether a prescription satisfies all applicable requirements is a case-specific question. We recommend confirming the current position with the prescriber, dispensing pharmacy, and qualified legal or regulatory counsel.
Is compounded tirzepatide still available?
It may be available in limited circumstances. A product listing does not prove that the drug is lawful, clinically appropriate, or available for shipment to a particular state.
Before relying on an availability claim, check the FDA Drug Shortages Database and the FDA’s current notices about compounded GLP-1 drugs.
Why do people say compounded tirzepatide was banned?
During the shortage, qualifying compounders had more scope to make copies of approved tirzepatide products. Once the shortage was declared resolved, the broader shortage-based allowances ended after the relevant transition and enforcement periods.
Calling this a “ban” misses the distinction between routine copying and compounding for a documented patient-specific need. FDA policies, court proceedings, and state rules can also change, so current guidance matters.
Compound Tirzepatide vs Tirzepatide, Zepbound, and Mounjaro
Tirzepatide is the active ingredient in the FDA-approved drugs Zepbound and Mounjaro. Compounded tirzepatide is a separate finished product.
| Feature | Compounded tirzepatide | Zepbound | Mounjaro |
|---|---|---|---|
| FDA approved | No | Yes | Yes |
| FDA-approved indication | None | Uses listed in its current label | Type 2 diabetes |
| Form | Often a multidose vial | Approved labeled presentation | Approved labeled presentation |
| Manufacturing review | Not reviewed as an approved drug | FDA reviewed | FDA reviewed |
| Concentration | May vary | Set by approved presentation | Set by approved presentation |
| Insurance coverage | Often excluded | Plan-dependent | Plan-dependent |
| Source | Compounding pharmacy or outsourcing facility | Authorized supply chain | Authorized supply chain |
The same active ingredient does not establish equal potency, sterility, stability, absorption, or clinical performance. We see no sound basis for claiming that compounded tirzepatide is inherently better than an approved product.
Why compounded tirzepatide is not a generic drug
A generic drug must undergo FDA review and receive approval. Compounded tirzepatide has not been approved as a generic version of Zepbound or Mounjaro.
We recommend treating phrases such as “generic Zepbound” as warning signs because they misstate the product’s regulatory status.
Is compounded tirzepatide FDA approved?
No. The FDA does not review each compounded drug for safety, effectiveness, and quality before sale in the same way it reviews an approved product.
A pharmacy license, facility registration, inspection, or accreditation does not make the finished drug FDA approved.
When Compounding May Be Allowed After the Shortage
Federal law restricts compounding of products that are essentially copies of approved drugs. Shortage status affects how some of those restrictions apply.
A lower price, standard dose, or general preference may not establish a permitted compounding need. State law can impose additional prescribing, licensing, and shipping requirements. Our summary is educational and not legal advice.
503A compounding pharmacies
A section 503A pharmacy generally compounds in response to patient-specific prescriptions and operates under state pharmacy oversight. It is not an FDA-approved drug manufacturer.
We recommend matching the pharmacy’s legal name and address on the vial with the relevant board of pharmacy record. Confirm that its license is active and permits shipment to the patient’s state.
503B outsourcing facilities
A 503B outsourcing facility registers with the FDA and assumes specific federal manufacturing, inspection, and reporting obligations. Registration does not mean the FDA has approved every drug the facility makes.
Facility type alone cannot establish whether a particular tirzepatide product may legally be compounded or dispensed.
Patient-specific clinical differences
A permitted clinical difference is fact-specific. The prescriber and pharmacist should document why a compounded form is required.
Adding a vitamin, changing the dose, or using a vial does not automatically establish a valid need. Ask what clinical issue the change addresses and how it is documented.
Tirzepatide Base, Salt Forms, and Added Ingredients
Ask whether the active ingredient is tirzepatide base or another form. A chemical name alone does not confirm purity, source, strength, or lawful use.
We also recommend requesting the full ingredient list, including inactive ingredients, preservatives, and additions such as B6, B12, or glycine.
An added vitamin does not prove greater weight loss or fewer side effects. Evidence from trials of FDA-approved tirzepatide products cannot automatically be applied to every compounded formulation.
Does “same active ingredient” mean the same product?
No. Finished products may differ in:
- Concentration
- Inactive ingredients
- Container and closure
- Storage limits and stability
- Sterility controls
- Delivery device
Ingredient sourcing and lot-specific testing may also differ. Any claim of equivalence needs reliable evidence.
Questions to ask about B6 or B12
Ask the prescriber and pharmacist:
- Which ingredient and amount does the vial contain?
- Why was it selected?
- What evidence supports the claimed benefit?
- What side effects or interactions apply?
- Does it affect storage or the beyond-use date?
How to Read a Compounded Tirzepatide Label Without Guessing
We do not recommend using a universal compound tirzepatide dosage chart. Concentrations can differ between pharmacies and prescriptions.
Milligrams measure drug mass, while milliliters measure liquid volume. Syringe units are volume markings on certain syringes. The basic relationship is:
Dose in mg = concentration in mg/mL × volume in mL
This formula explains a label; it is not personal dosing advice. The same injection volume can contain different doses when vial concentrations differ.
Seven details to confirm before an injection
Confirm:
- Patient name and prescription number
- Prescribed dose in milligrams
- Concentration in milligrams per milliliter
- Injection volume and corresponding syringe mark
- Syringe type and capacity
- Full ingredient list
- Storage range and beyond-use date
Follow the dispensing pharmacy’s instructions for particles, cloudiness, leaks, or damage. Rules from another product’s label may not apply.
Why copied dosing charts can cause errors
An online chart may assume a different concentration, vial strength, device, or syringe. Dose changes must come from the treating clinician, not a copied conversion chart.
The same caution applies when reviewing vial checks for compounded semaglutide.
What to do when directions conflict
Do not inject until the prescriber or dispensing pharmacist resolves the discrepancy. Request written directions that state the dose, concentration, injection volume, and syringe mark.
Never share vials, pens, syringes, or needles.
Storage, Shipping, Beyond-Use Dates, and Pharmacy Checks
A “best pharmacy” list is not enough. Verify the pharmacy’s license, legal name, location, and authority to ship into the patient’s state.
Licensing, 503B registration, accreditation, inspection records, and laboratory reports provide different information. None replaces the others. Storage requirements and the beyond-use date must come from the specific product’s label, not from Zepbound or Mounjaro instructions.
How to verify an online pharmacy
Before payment:
- Confirm the prescriber’s license
- Identify the dispensing pharmacy’s legal name
- Check the appropriate state board of pharmacy
- Confirm authority to ship into the patient’s state
- Review relevant FDA alerts, recalls, and warning letters
- Ask whether testing matches the lot on the vial
What to check when a shipment arrives
Check the patient name, drug, concentration, ingredients, lot number, storage range, beyond-use date, and pharmacy contact details.
Follow written pharmacy instructions if a shipment arrives warm, frozen, late, cloudy, leaking, or damaged. Do not use it until any label or temperature concern has been resolved.
Effects, Side Effects, and Reasons to Get Help
FDA-approved tirzepatide products affect GIP and GLP-1 receptors. Their labeled adverse effects include gastrointestinal symptoms such as nausea, diarrhea, vomiting, constipation, abdominal discomfort, and indigestion.
Data from approved products do not prove that every compounded formulation has the same potency, stability, sterility, or clinical performance.
Approved tirzepatide labels also carry a boxed warning concerning thyroid C-cell tumors observed in animals. A clinician must review contraindications and individual risk before prescribing.
Report adverse effects and product defects to the prescriber and pharmacy. Reports may also be submitted to FDA MedWatch.
Health history and medicine review
A clinical review should cover pregnancy, pancreatitis or gallbladder concerns, kidney problems, severe gastrointestinal disease, allergies, and other medicines.
Particular attention may be needed for insulin, sulfonylureas, and oral medicines whose absorption could be affected. Patients using oral hormonal contraceptives should ask their clinician about the precautions in the current FDA-approved label.
When to seek urgent or emergency care
Contact a clinician promptly for severe abdominal pain, persistent vomiting, dehydration, or severe or worsening symptoms.
Seek emergency care for trouble breathing, facial or throat swelling, fainting, or signs of a serious allergic reaction.
What Compounded Tirzepatide Really Costs
A low advertised medication price may exclude required services. We recommend comparing the full cost over the same treatment period.
Possible charges include:
- Clinical visits and laboratory work
- Medication and dose-based price changes
- Shipping and cold packaging
- Syringes and other supplies
- Membership, platform, or refill fees
- Cancellation charges
Review refund terms for denied prescriptions, unused membership time, and canceled shipments. Compare approved alternatives only after checking current cash prices, insurance terms, savings-program rules, and eligibility.
A total-cost checklist
Ask:
- What is charged before clinical review?
- Does the price change with dose?
- Are shipping and supplies included?
- Are follow-ups and labs included?
- When does the next billing cycle begin?
- What happens after cancellation?
Questions for no-membership plans
“No membership” does not always mean no additional fees. Confirm whether visits, refills, support, or platform access cost extra.
Identify who manages side effects, treatment changes, pharmacy questions, and shipping problems.
How to Plan a Refill and Evaluate Online Care
Begin the refill process before the vial is nearly empty. Confirm the clinical review deadline, prescription status, dispensing pharmacy, shipping method, and available alternatives.
Eligibility, clinician approval, product selection, and pharmacy fulfillment are separate decisions. A platform should not guarantee all of them.
We help patients organize medication details and refill needs through Temi’s medication platform. Clinical approval and fulfillment remain the responsibility of the licensed professionals and entities involved.
Refill questions to ask before paying
Ask:
- When will clinical review occur?
- Which pharmacy may fill the prescription?
- Can it ship to the patient’s state?
- What is the total current cost?
- Can the price change after review?
- What happens if no prescription is issued?
- Who handles a delayed shipment?
A safe next step when supply may run out
Contact the prescribing team early. Do not stretch doses, change the amount, or combine leftover vials without instructions.
Ask about FDA-approved products or other appropriate treatments if a compounded drug is unavailable. A clinician and pharmacist should oversee any transition.
Source, review, and update standard
We base our guidance on current FDA labels, shortage records, compounding notices, safety communications, and pharmacy-license records. Policies and state rules can change, so readers should verify current requirements.
This article provides education, not medical or legal advice. Follow the exact label and directions supplied by the individual prescriber and dispensing pharmacist.
FAQ
Is compounded tirzepatide better than regular tirzepatide?
No blanket claim is supported. Zepbound and Mounjaro are FDA-approved products. A compounded version may address a documented patient need, but its concentration, ingredients, testing, cost, and availability can differ.
Is compounded tirzepatide still available?
It may be available for some patient-specific prescriptions when federal and state requirements are met. A website listing does not confirm lawful access, suitability, or availability in a particular state.
Why is compounded tirzepatide banned?
There was no single blanket ban on every compounded prescription. Resolution of the shortage restricted routine copying, while narrower patient-specific pathways may remain under applicable law.
What is the difference between compound tirzepatide and tirzepatide?
Tirzepatide is an active ingredient. Zepbound and Mounjaro are FDA-approved finished drugs. Compounded tirzepatide is a separate, unapproved finished product prepared by a pharmacy or outsourcing facility.
Can syringe units be converted directly to milligrams?
Not without knowing the vial concentration. Syringe units indicate volume, while milligrams indicate drug mass. The prescriber or pharmacist should confirm the dose, concentration, volume, and syringe mark in writing.
Get Help With Your Next Refill
Gather the vial label, current directions, dose history, and remaining supply, then use our prescription refill support to identify the next step. Do not change a dose or use a product with conflicting directions while waiting for professional guidance.
